INKT stock

Mink Therapeutics Inc (INKT) financials · $59.1M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Mink Therapeutics Inc (INKT) $59.1M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$12.6M-$11.3M
Net Income-$12.5M-$10.8M
EPS (Diluted)-$2.93-$2.86
Cached annual balance sheet
LineFY2025FY2024
Total Assets$14.2M$5.72M
Current Assets$13.8M$4.99M
Cash & Equivalents$13.4M$4.58M
PP&E$390.9K$732.9K
Total Liabilities$28.5M$25.3M
Current Liabilities$13.0M$6.96M
Shareholders' Equity-$14.2M-$19.6M
Retained Earnings-$156.7M-$144.2M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$5.93M-$9.56M
Financing Cash Flow$14.7M$10.8M
Net Change in Cash$8.78M$1.21M
These statements as JSON? API free 100/day

FAQ

What is INKT P/E and revenue?

Mink Therapeutics Inc (INKT) $59.1M cap.

What is INKT revenue?

INKT income-statement cache has no revenue figure yet.

Is INKT profitable?

Mink Therapeutics Inc last cached net income is -$12.5M (FY2025).

What are INKT total assets?

Mink Therapeutics Inc last cached total assets are $14.2M (FY2025).

What is INKT free cash flow?

No cached cash-flow row for INKT yet.

Not investment advice. Cached statements, not a live tape.